Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-14-029444
Filing Date
2014-07-25
Accepted
2014-07-25 17:28:55
Documents
1
Period of Report
2014-07-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 2954
  Complete submission text file 0001140361-14-029444.txt   4347
Mailing Address 890 SANTA CRUZ AVENUE MENLO PARK CA 94025
Business Address 890 SANTA CRUZ AVENUE MENLO PARK CA 94025 650-847-1919
AntriaBio, Inc. (Issuer) CIK: 0001509261 (see all company filings)

EIN.: 273440894 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 890 SANTA CRUZ AVENUE MENLO PARK CA 94025
Business Address
Sherman Barry Michael (Reporting) CIK: 0001614973 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-54495 | Film No.: 14994976